Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hong Kong Hospital Authority To Test 3,000 Drugs, Add Suppliers

This article was originally published in PharmAsia News

Executive Summary

Hong Kong's hospital system is establishing a nearly U.S.$4 million safety system to double check the purity of the drugs it buys, and spread its purchases among several distributors. The action is being taken by the Hospital Authority in the wake of death of at least five patient due to a contaminated generic version of Europharm's Purinol (allopurinol). An investigation found generic drugs for public hospitals came from a single distributor. The authority now plans to commission tests on more than 3,000 drugs its hospitals receive to be sure they are not contaminated by bacteria, fungi or yeast. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts